Skip to content

Use of Antibiotic Carrier in Acute Periprosthetic Infections (APPI) of Total Knee Replacements

Use of Antibiotic Contained Calcium Sulfate Carrier in Acute Periprosthetic Infections(APPI) of Total Knee Replacements

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02107924
Enrollment
0
Registered
2014-04-08
Start date
2014-04-30
Completion date
2015-12-31
Last updated
2014-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

Total, Knee, Replacment, Infection, Stimulan

Brief summary

The purpose of the study is to gather information on the use of Stimulan, the surgery, and anitbiotics to whetether the APPI has decreased or shown improvement when compared to study participants who did not receive Stimulan during their revision total knee replacement surgery.

Interventions

PROCEDUREAPPI of TKR-Stimulan

Sponsors

The Methodist Hospital Research Institute
CollaboratorOTHER
Michael Muldoon, M.D.
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* APPI within 28 days of primary TKR * Acute hematogenous infection within 4 weeks of symptoms

Exclusion criteria

* Exposed prosthesis * Infection occuring in revised joints * Poly articular infections * have allergies to tobramycin or Vancomycin * previous chronic infections in or around any ipsilateral extremity trauma or implants

Design outcomes

Primary

MeasureTime frame
Retention of components12 months
Eradication of infection12 months

Secondary

MeasureTime frame
Knee Society Score12 months
Visual Analog Scale12 months
Outcome Assessment Scores12 months
C-Reactive protein (CRP)12 months
AP and lateral Radiographs of involved joint12 months
Positive synovial fluid cell countpre-operative
Sedimentation Rate12 months
Ongoing use of antibiotics6 weeks
Wound complications12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026